Tenders Are Invited For Pharmacy Services-75.2025 Placebo Production Service For The Needs Of Clinical Examination And Product Management Service For The Needs Of The Project A Randomized, Double-Blind, Three Parall-Group, Placebo Controlled Superiority Trial Assessing The Effect Of Intravenous Versus Oral Iron Supplymentation On Physical Performance In Iron Deficent Frail Eldividules With Cardiovascular Disca

Pharmacy Services-75.2025 Placebo Production Service For The Needs Of Clinical Examination And Product Management Service For The Needs Of The Project A Randomized, Double-Blind, Three Parall-Group, Placebo Controlled Superiority Trial Assessing The Effect Of Intravenous Versus Oral Iron Supplymentation On Physical Performance In Iron Deficent Frail Eldividules With Cardiovascular Disca. 1. The Subject Of The Contract Is: A Placebo Production Service For The Needs Of A Clinical Trial And A Test Management Service Including Documentation, Labeling, Repacking And Dismissal For Use In A Clinical Trial; Storing The Studied Products Together With Their Inventory, Release From The Warehouse, Transport To Clinical Centers And Utilization For The Needs Of The Project A Randomized, Double-Blind, Three Parallel-Group, Placebo Controlled Superiority Trial Assessing The Effect Of Intrcrvenous Versus Oral Iron Performance In Iron Deficent Frail Eldividuals With Cardiovascular Disease. Placebo Tardyferon Or Equivalent, C) Task 3 Product For Clinical Trial - Taking Into Account The Transfer Of Tardyferon Or Equivalent Tablets (Ferrous Sulfate, 80 Mg) To New Unit Bottles - In The Amount Of 54,000, - Delivery, Appropriate Marking, Transitization And Release Of The Product For Clinical Examination - Ferinject Or Equivalent (500 Mg Of Carboxymaltose, 10 Ml) In 830 Ml), 830 Ml), 830 Ml) - Acceptance Of The Delivery Of Sodium Chloride 0.9% (Nacl) In A Volume Of 100 Ml, Necessary For The Preparation Of Solutions For Intravenous Administration (Placebo And The Test Product) In The Amount Of 1250 Pieces, D) Task 4. Transport To The Centers Indicated By The Employer And Logistics Management (Together With Documentation) Products, E) Task 5. Storage Of All Products, F) Task 6 Examined After The End Of The Project. The Following Requirements Will Meet: 1) They Will Contain The Same Active Substance In The Same Dose And Release Form, Without The Addition Of Other Active Substances; (E.G. Oral, Intravenous); 4)

10,94,000 - PLN

FileName	File Description
Global Tender Document	Tender Notice